Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis.

Leukemia - 1 Dec 2017

Maekawa T, Osawa Y, Izumi T, Nagao S, Takano K, Okada Y, Tachi N, Teramoto M, Kawamura T, Horiuchi T, Saga R, Kato S, Yamamura T, Watanabe J, Kobayashi A, Kobayashi S, Sato K, Hashimoto M, Suzu S, Kimura F

Abstract excerpt

Myelofibrosis (MF) may be caused by various pathogenic mechanisms such as elevation in circulating cytokine levels, cellular interactions and genetic mutations. However, the underlying mechanism of MF still remains unknown. Recent studies have revealed that fibrocytes, the spindle-shaped fibroblast-like hematopoietic cells, and the thrombopoietin (TPO)/myeloproliferative leukemia protein (MPL; TPO receptor)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Hematopoietic Stem Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Monocytes

Share to Primary Myelofibrosis

Share to Receptors, Thrombopoietin

Share to STAT Transcription Factors

Share to Thrombopoietin

Source

Identifiers

PMID: 28386106
DOI: 10.1038/leu.2017.112

Genes

MPL
TPO

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis.PMID 28386106Read ↗

Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies.Semantic proximity Read ↗

ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms.Semantic proximity Read ↗

Myelofibrosis: challenges for preclinical models and emerging therapeutic targets.Semantic proximity Read ↗

Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice.Semantic proximity Read ↗

Rationale for combination therapy in myelofibrosis.Semantic proximity Read ↗

Understanding deregulated cellular and molecular dynamics in the haematopoietic stem cell niche to develop novel therapeutics for bone marrow fibrosis.Semantic proximity Read ↗

CXCL8/CXCR2 signaling mediates bone marrow fibrosis and represents a therapeutic target in myelofibrosisSemantic proximity Read ↗

Flow Cytometric Identification of Fibrocytes in the Human Circulation.Semantic proximity Read ↗

A humanized ossicle model of myelofibrosis reveals THPO-driven fibrosis, osteosclerosis and SPP1-dependent microenvironmental remodelingSemantic proximity Read ↗

Monocyte and macrophage derived myofibroblasts: Is it fate? A review of the current evidenceSemantic proximity Read ↗

Circulating fibrocytes: a potent cell population in antigen-presenting and wound healing.Semantic proximity Read ↗

Inhibition of the EBF1-ITGB8 Axis in Bone Marrow Niche Ameliorates Hallmarks of MyelofibrosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.